William R. Shanahan
No más puestos en curso
Historial de carrera de William R. Shanahan
Antiguos cargos conocidos de William R. Shanahan.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 15/08/2016 | 15/04/2018 |
| ARENA PHARMACEUTICALS | Director Técnico/Científico/I+D | 01/03/2004 | 13/06/2016 |
Tanox, Inc.
 Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Director Técnico/Científico/I+D | 01/08/2000 | 01/03/2004 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/1994 | 01/08/2000 |
| PFIZER, INC. | Director Técnico/Científico/I+D | 01/01/1990 | 01/01/1994 |
| Searle Research & Development | Director Técnico/Científico/I+D | 01/01/1986 | 01/01/1989 |
| University of Connecticut | Corporate Officer/Principal | - | - |
Formación de William R. Shanahan.
| Dartmouth College | Undergraduate Degree |
| Loyola University of Chicago | Graduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 11 |
Operativa
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 5 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| ANTHERA PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
| Searle Research & Development |
- Bolsa de valores
- Insiders
- William R. Shanahan
- Experiencia